Continuing my conversation with Dr. Joe Jeffers regarding stem-cell research, I asked for his reaction to a statement by Dr. James Thomson, the discoverer of embryonic stem cells: “If human embryonic stem-cell research does not make you at least a little bit uncomfortable, you have not thought about it enough.”
Jeffers: Any system can be abused. Having a commercial clinic hire people to bring in the eggs and sperm to create blastocysts would not meet the ethical standards by which science is done in this country. But could such a clinic produce blastocysts that could be harvested for embryonic stem cells? You bet! Anything is subject to misuse. That is why we have some general ethical principles by which science is done.
Downs: What’s the potentially good news about stem cells?
Jeffers: Pluripotent stem cells have the potential to differentiate into cells of virtually any organ-heart, brain, blood, etc. Cells are considered pluripotent if they have been grown in culture for six months without beginning to differentiate into other cell types. We have two sources of pluripotent stem cells—blastocysts and adult cells that have been triggered to revert to stem cells. We also have partially differentiated adult stem cells in various organs. So organ repair or replacement therapies could develop from stem cell research. Consider another promising area. If a drug company is trying to develop medications that are effective against cystic fibrosis or other known genetic disorders, then working with stem cells that contain these disorders provides a great opportunity to develop effective drug therapies.
Downs: What are the steps involved in developing stem cells that would morph into hearts or a kidneys or other organs?
Jeffers: The first step is to learn what triggers a cell to change. Ultimately, we want to stimulate cells to develop into heart cells, kidney cells, etc., to address a medical issue. But right now, we don’t know how. Studying the development of pluripotent stem cells as they differentiate will provide those clues. Animal models help, but there are too many differences to rely on animal models alone.
Downs: But you are optimistic that this can eventually be done?
Jeffers: I have no doubt that we will be able to do it. Again, the point is that we have to know how the system works. And the best way to do this is to start with the cells that begin the process and see what the triggers are that cause them to develop. We know some of these triggers, but not nearly enough of them.